Michele Genna

University of Verona

Papers

1

Total Citations

1

H-Index

1

About

Michele Genna is a pioneering colorectal surgeon whose research focuses on the comparative effectiveness of robotic surgical platforms for colon cancer treatment. His major contribution lies in advancing the evidence base for minimally invasive surgery, particularly through the COMPAR-CRC multiplatform study, the first prospective case series to directly compare outcomes across three CE-marked robotic systems: the established Da Vinci Xi, the Hugo™ RAS, and the Versius®. This landmark 2025 work, already garnering citations, provides critical insights into the technical advantages and clinical outcomes of each platform, helping surgeons worldwide make informed decisions about technology adoption. Genna’s research addresses the pressing need for real-world data on emerging robotic systems, directly impacting surgical practice and patient care. His work is notable for its rigorous, multi-institutional design and its timely relevance as new platforms enter the European market. By systematically evaluating these technologies, Genna is shaping the future of robot-assisted colorectal surgery, offering a roadmap for safer, more effective cancer resections.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of outcomes in robot-assisted colon cancer surgery using Da Vinci Xi, Hugo™ RAS, and Versius®: The COMPAR-CRC multiplatform study
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Verona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago